Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Curcumin in Advanced Pancreatic Cancer
NCT00192842Phase 2Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Jul 2004
- Primary completion
- Nov 2007
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
01
Overview
Phase 2, single-arm trial of curcumin in pancreatic cancer (PC), sponsored by Rambam Health Care Campus. Primary endpoint: Time to Tumor Progression. Started Jul 2004; status: completed.
02
Drugs
curcumin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00192842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192842.